| FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Reuters |
|
|
ReutersIn patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (eg, patients with severe CHF), treatment with ... read more |